Surface Molecularly Engineered Mitochondria Conduct Immunophenotype Repolarization of Tumor‐Associated Macrophages to Potentiate Cancer Immunotherapy
Advanced Science · 2024
DOI: 10.1002/advs.202403044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Cai-Ju Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China. Hauptthemen laut MEDLINE: Immunotherapy, Mitochondria, Tumor-Associated Macrophages. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Youth Interdisciplinary Special Fund of Zhongnan Hospital of Wuhan University.
Abstract (Originalsprache)
Reprogramming tumor‐associated macrophages (TAMs) to an inflammatory phenotype effectively increases the potential of immune checkpoint blockade (ICB) therapy. Artificial mitochondrial transplantation, an emerging and safe strategy, has made brilliant achievements in regulating the function of recipient cells in preclinic and clinic, but its performance in reprogramming the immunophenotype of TAMs has not been reported. Here, the metabolism of M2 TAMs is proposed resetting from oxidative phosphorylation (OXPHOS) to glycolysis for polarizing M1 TAMs through targeted transplantation of mannosylated mitochondria (mPEI/M1mt). Mitochondria isolated from M1 macrophages are coated with mannosylated polyethyleneimine (mPEI) through electrostatic interaction to form mPEI/M1mt, which can be targeted uptake by M2 macrophages expressed a high level of mannose receptors. Mechanistically, mPEI/M1mt accelerates phosphorylation of NF‐κB p65, MAPK p38 and JNK by glycolysis‐mediated elevation of intracellular ROS, thus prompting M1 macrophage polarization. In vivo, the transplantation of mPEI/M1mt excellently potentiates therapeutic effects of anti‐PD‐L1 by resetting an antitumor proinflammatory tumor microenvironment and stimulating CD8 and CD4 T cells dependent immune response. Altogether, this work provides a novel platform for improving cancer immunotherapy, meanwhile, broadens the scope of mitochondrial transplantation technology in clinics in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China.
- Department of Radiology, Hainan Hospital Affiliated to Hainan Medical University, Hainan, 570311, China.
- Key Laboratory of Biomedical Polymers of Ministry of Education, Department of Chemistry, Wuhan University, Wuhan, 430072, China.
- Department of Radiology, Renmin Hospital of Wuhan University, Jiefang Road 238,Wuchang District, Wuhan, Hubei, 430060, China.
- Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China.
- Department of Orthopedic Trauma and Microsurgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
ORCID-Profile: Kai Deng
Förderung
- National Natural Science Foundation of China
- Youth Interdisciplinary Special Fund of Zhongnan Hospital of Wuhan University
Zitieren
APA
Zhang, C. J., Li, J. M., Xu, D., Wang, D. D., Qi, M. H., Chen, F., Wu, B., Deng, K., & Huang, S. W. (2024). Surface Molecularly Engineered Mitochondria Conduct Immunophenotype Repolarization of Tumor‐Associated Macrophages to Potentiate Cancer Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202403044
Vancouver
Zhang CJ, Li JM, Xu D, Wang DD, Qi MH, Chen F, et al. Surface Molecularly Engineered Mitochondria Conduct Immunophenotype Repolarization of Tumor‐Associated Macrophages to Potentiate Cancer Immunotherapy. Advanced Science. 2024. doi:10.1002/advs.202403044
BibTeX
@article{Zhang2024,
author = {Zhang, Cai-Ju and Li, Jia-Mi and Xu, Dan and Wang, Dan-Dan and Qi, Ming-Hui and Chen, Feng and Wu, Bo and Deng, Kai and Huang, Shi-Wen},
title = {Surface Molecularly Engineered Mitochondria Conduct Immunophenotype Repolarization of Tumor‐Associated Macrophages to Potentiate Cancer Immunotherapy},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202403044}
}
EUVIMED